Literature DB >> 1999323

Hypercholeresis induced by unconjugated bile acid infusion correlates with recovery in bile of unconjugated bile acids.

D Gurantz1, C D Schteingart, L R Hagey, J H Steinbach, T Grotmol, A F Hofmann.   

Abstract

Using the isolated perfused rat and hamster liver, the relationship between bile flow, bile acid secretion rate and bile acid biotransformation after the injection of a small, bolus dose of radioactive ursodeoxycholate or of its C23 homolog, norursodeoxycholate, was examined. Ursodeoxycholate was promptly secreted into bile mostly as amino acid conjugates; less than 3% was secreted in unchanged form in the rat and less than 2% in the hamster. In contrast, norursodeoxycholate was secreted slowly, and biotransformed into glucuronide conjugates and unconjugated trihydroxy derivatives; it was also secreted in part in unchanged form. In the rat, 7% was secreted in unconjugated trihydroxy derivatives and 3% in unchanged form; in the hamster, 7% was secreted as unconjugated trihydroxy derivatives and 4% in unchanged form. The secreted bile acid species that showed the highest correlation with bile flow by far was always the unconjugated form in both rat and hamster. By multiple regression analysis, the apparent choleretic activity (microliters of induced bile flow per micromoles recovered bile acid molecules) indicated marked hypercholeresis for the unconjugated bile acid marked hypercholeresis for the unconjugated bile acid with values ranging from 100 to 300 microliters/mumol. Bile flow also correlated with total bile acid recovery for ursodeoxycholate in rat and norursodeoxycholate in hamster, but in all studies the apparent choleretic activity was far lower. Other calculations indicated that most bile flow during the first 30 min was induced by secretion of the unconjugated bile acid species in all experiments, the proportion ranging from 50% to 90%. The results indicate that when a bolus of ursodeoxycholate or norursodeoxycholate is presented to the perfused rodent liver, the secretion of the unchanged bile acid appears to be responsible for most of the bile flow, probably by a cholehepatic shunting mechanism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999323

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

Review 1.  Acid-base transport systems in gastrointestinal epithelia.

Authors:  D Gleeson
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

2.  If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.

Authors:  Kari Nejak-Bowen
Journal:  Gene Expr       Date:  2019-08-22

Review 3.  Bile acid interactions with cholangiocytes.

Authors:  Xuefeng Xia; Heather Francis; Shannon Glaser; Gianfranco Alpini; Gene LeSage
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

4.  Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter.

Authors:  K N Lazaridis; L Pham; P Tietz; R A Marinelli; P C deGroen; S Levine; P A Dawson; N F LaRusso
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 5.  Emerging pharmacologic therapies for primary sclerosing cholangitis.

Authors:  Angela C Cheung; Konstantinos N Lazaridis; Nicholas F LaRusso; Gregory J Gores
Journal:  Curr Opin Gastroenterol       Date:  2017-05       Impact factor: 3.287

Review 6.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

7.  Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function.

Authors:  Y Asamoto; S Tazuma; H Ochi; K Chayama; H Suzuki
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

8.  Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages.

Authors:  P Ljubuncic; B Fuhrman; J Oiknine; M Aviram; A Bomzon
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

Review 9.  Role of bile acids in inflammatory liver diseases.

Authors:  Ioannis Evangelakos; Joerg Heeren; Esther Verkade; Folkert Kuipers
Journal:  Semin Immunopathol       Date:  2021-07-08       Impact factor: 9.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.